MAR 15, 2019 12:41 AM PDT

Vaccine Blocks Osteoarthritis Pain in Mice

WRITTEN BY: Nouran Amin

A virus-like particle vaccine was developed to stop chronic pain caused by osteoarthritis inhibiting a nerve growth factor (NGF). The vaccine was administered in mice who exhibited symptoms of painful osteoarthritis and was shown to visibly reverse these effects. The vaccine works by triggering the immune system to produce antibodies to block naturally-occurring NGF. “I’m happy to see the vaccine platform perform so well, and look forward to seeing the vaccine enter clinical testing in companion animals,” said co-lead author Professor Martin Bachmann, from the Jenner Institute at the University of Oxford and the University of Bern.

Pain in osteoarthritis poses a substantial social and economic burden with fewer than 25% of patients having adequate pain control. NGF has emerged as a key driver of pain behavior in murine studies and antibodies to NGF are potent analgesics in human osteoarthritis. Using a novel virus-like particle, von Loga et al created a therapeutic vaccine that reversibly induced antibodies against NGF and abrogated pain behavior in murine osteoarthritis.

Image credit: OpenStax / CC BY 4.0.

“This is the first successful vaccination to target pain in osteoarthritis, one of the biggest healthcare challenges of our generation,” said co-lead author Professor Tonia Vincent, a researcher at the Kennedy Institute of Rheumatology at the University of Oxford.“Whilst there are still safety issues that need to be considered before these types of approaches can be used in patients, we are reassured that this vaccine design allows us to control antibody levels and thus tailor treatment to individual cases according to need.”

Current pain relief therapeutics for osteoarthritis include NSAID’s and opioids. However, NGF is a promising target for osteoarthritis pain.

“Too many people living with pain do not get effective relief from the treatments that are currently available, and that is why the development of more effective painkillers, with fewer side-effects, is vital for people living with arthritis,” said Dr. Stephen Simpson, Director of research at Versus Arthritis, which funded the study. “Although at an early stage, this is highly innovative research and these results are very promising.”

Findings of the study were published in Annals of Rheumatic Disease.

Source: Sci-News

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 23, 2018
Cannabis Sciences
NOV 23, 2018
Rimonabant: A Cautionary Tale for Targeting the Endocannabinoid System
The evidence that the endocannabinoid system (ECS) is intimately involved in food intake has been steadily increasing. Thus, in attempts to treat obesity,...
DEC 27, 2018
Microbiology
DEC 27, 2018
Reputed Medicinal Soil Yields a Superbug-killing Bacterium
It's no secret that antibiotic resistance is a problem that already poses a serious threat to public health, and it's expected to get worse....
JAN 23, 2019
Drug Discovery
JAN 23, 2019
Frequent Aspirin Use Can Lead to Increased Bleeding
According to a systemic study published in the Journal of the American Medical Association (JAMA), taking aspirin regularly may prevent heart attacks and s...
FEB 11, 2019
Chemistry & Physics
FEB 11, 2019
Actinium-based Targeted Alpha Therapy Delivers A Combo Punch
Radiotherapy is a staple among many medical interventions to treat cancer. Besides external beam radiotherapy and sealed radio-source therapy, it is common...
FEB 25, 2019
Drug Discovery
FEB 25, 2019
3D Hydrogel Advances Drug Discovery
Researchers have developed a 3D hydrogel based on hyaluronic acid, a biocompatible substance. The gel could quickly and effectively screen hundreds of pote...
MAR 13, 2019
Drug Discovery
MAR 13, 2019
Combination Immunotherapy Stops Liver Cancer Growth
The number of individuals diagnosed with liver cancer is on the rise and current therapies are largely ineffective. However, new preclinical data from the ...
Loading Comments...